Evidence map›Paper›PMID 29860251›Full record

Trial reportPsychotherapy and psychosomatics2018

The Efficacy of a Group CBT Relapse Prevention Program for Remitted Anxiety Disorder Patients Who Discontinue Antidepressant Medication: A Randomized Controlled Trial.

Willemijn D Scholten, Neeltje M Batelaan, Patricia van Oppen, Johannes H Smit, Adriaan W Hoogendoorn, Harold J G M van Megen, Daniëlle C Cath, Anton J L M van Balkom

Abstract readLetterRandomized Controlled Trial
In one paragraph

Trial report in Psychotherapy and psychosomatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Outcomes of hyperbolic tapering of antidepressants.Therapeutic advances in psychopharmacology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Willemijn D ScholtenDepartment of Psychiatry, GGZ ingest, Amsterdam, the Netherlands.
Neeltje M BatelaanDepartment of Psychiatry, GGZ ingest, Amsterdam, the Netherlands.
Patricia van OppenDepartment of Psychiatry, GGZ ingest, Amsterdam, the Netherlands.
Johannes H SmitDepartment of Psychiatry, GGZ ingest, Amsterdam, the Netherlands.
Adriaan W HoogendoornDepartment of Psychiatry, GGZ ingest, Amsterdam, the Netherlands.
Harold J G M van MegenInnova Research Centre, Mental Health Care Institute, GGZ Centraal, Ermelo, the Netherlands.
Daniëlle C CathAltrecht Academic Anxiety Center, Utrecht, the Netherlands.
Anton J L M van BalkomDepartment of Psychiatry, GGZ ingest, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antidepressive AgentsAnxiety DisordersCognitive Behavioral TherapySecondary PreventionHumansRecurrenceTreatment OutcomeAntidepressive Agents

Identifiers

PMID29860251
PMCPMC6492611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.